Celldex Therapeutics CLDX
NASDAQ CLDX
$31.65 +0.16 (+0.51%)
As of: Sep 29, 2026 · 3:59 PM EDT

Celldex Therapeutics (CLDX) Goodwill impairment charges (2018)

Updated

Celldex Therapeutics (CLDX) recorded Goodwill impairment charges of $90.98 million in FY2018.

Analysis

Celldex Therapeutics (CLDX) Goodwill impairment charges (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Celldex Therapeutics 2.47 Bn 2.47 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 90.98 Mn
API Access

Celldex Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=CLDX&period=max&api_key=YOUR_API_KEY